Medicine and Dentistry
Breast Cancer
100%
Patient
85%
Therapeutic Procedure
41%
Diseases
27%
Hormone Therapy
25%
Woman
25%
Neoplasm
24%
Combination Therapy
24%
Malignant Neoplasm
23%
Recurrent Disease
17%
Inpatient
17%
Gene
16%
Age
14%
Metastatic Breast Cancer
14%
Estrogen Receptor
13%
Triple Negative Breast Cancer
11%
Single Nucleotide Polymorphism
9%
Tamoxifen
9%
Diagnosis
9%
Hormone Receptor
9%
BRCA1
9%
Chemotherapy
9%
Association
8%
Eribulin
8%
Breast
8%
Transforming Growth Factor
8%
Development
7%
Overall Survival
7%
Trastuzumab
7%
Adiponectin
7%
Behcet Disease
7%
Assessment
7%
Serum
7%
Progression Free Survival
6%
Cancer
6%
Survival
6%
Receptor
6%
Homologous Recombination
6%
Toxicity
6%
Gamma Urogastrone
6%
Epidermal Growth Factor Receptor 2
6%
Adjuvant Therapy
6%
Carboplatin
6%
Hispanic
6%
Growth
6%
Biological Marker
5%
Metastatic Carcinoma
5%
Aromatase Inhibitor
5%
Body Mass Index
5%
BRCA2
5%
Pharmacology, Toxicology and Pharmaceutical Science
Breast Cancer
69%
Neoplasm
20%
Malignant Neoplasm
20%
Metastatic Breast Cancer
17%
Diseases
15%
Chemotherapy
15%
Clinical Trial
12%
Trastuzumab
12%
Recurrent Disease
11%
Paclitaxel
10%
Capecitabine
10%
Cancer Risk
10%
Toxicity
10%
Leptin
9%
Lapatinib
8%
Hormone Receptor
7%
Gamma Urogastrone
7%
Elacestrant
7%
Sorafenib
6%
Progression Free Survival
6%
Anthracycline
6%
Triple Negative Breast Cancer
6%
Solid Malignant Neoplasm
6%
Receptor
6%
Overall Survival
6%
Tamoxifen
6%
Adiponectin
6%
Survival
5%
Epidermal Growth Factor Receptor 2
5%
Aromatase Inhibitor
5%
Placebo
5%
Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer
5%
Biochemistry, Genetics and Molecular Biology
Nested Gene
24%
Association
20%
Adiponectin
17%
Mutation
14%
Single-Nucleotide Polymorphism
13%
Transforming Growth Factor
11%
BRCA1
11%
Development
9%
Age
8%
Allele
8%
Growth
7%
Body Mass
7%
Cancer Cell
7%
Case-Control Study
7%
Homologous Recombination
7%
Weight
6%
Estrogen Receptor
6%
BRCA2
5%
Clinical Trial
5%
Colon
5%